Kate Litvak concludes:
The overall evidence is consistent with (i) SOX negatively affecting cross-listed premia and particularly hurting riskier and more-disclosing firms; and (ii) investor learning over time about its expected effects.
Next entry: Fantasy and the Law
Previous entry: Director Primacy via SOX?